Back
NewAmsterdam Pharma Co NV Stock Price Chart
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Sell
35
NAMS
NewAmsterdam Pharma Co NV
Last Price:
$24.96
Seasonality Move:
25.49%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
The current trend is moderately bearish and NAMS is experiencing selling pressure, which indicates risk of future bearish movement.
NewAmsterdam Pharma Co NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.7 | Sell |
| 20-day SMA: | 25.64 | Sell |
| 50-day SMA: | 22.89 | Buy |
| 200-day SMA: | 19.79 | Buy |
| 8-day EMA: | 25.58 | Sell |
| 20-day EMA: | 25 | Sell |
| 50-day EMA: | 23.12 | Buy |
| 200-day EMA: | 19.69 | Buy |
NewAmsterdam Pharma Co NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 53.26 | Buy |
| Chaikin Money Flow: | -447400 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.75 - 27.23) | Buy |
| Bollinger Bands (100): | (16.19 - 23.71) | Buy |
NewAmsterdam Pharma Co NV Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NewAmsterdam Pharma Co NV Stock
Is NewAmsterdam Pharma Co NV Stock a Buy?
-
NewAmsterdam Pharma Co NV share price is 24.95 while NAMS 8-day simple moving average is 25.70, which is a Sell signal.
-
The stock price of NAMS is 24.95 while NewAmsterdam Pharma Co NV 20-day SMA is 25.64, which makes it a Sell.
-
NewAmsterdam Pharma Co NV 50-day simple moving average is 22.89 while NAMS share price is 24.95, making it a Buy technically.
-
NAMS stock price is 24.95 and NewAmsterdam Pharma Co NV 200-day simple moving average is 19.79, creating a Buy signal.
NAMS Technical Analysis vs Fundamental Analysis
Sell
35
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Is NewAmsterdam Pharma Co NV a Buy or a Sell?
-
NewAmsterdam Pharma Co NV stock is rated a SellThe current NewAmsterdam Pharma Co NV [NAMS] share price is $24.95. The Score for NAMS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
NewAmsterdam Pharma Co NV Stock Info
Market Cap:
2.3B
Price in USD:
24.95
Share Volume:
637.5K
NewAmsterdam Pharma Co NV 52-Week Range
52-Week High:
27.29
52-Week Low:
15.19
Sell
35
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
NewAmsterdam Pharma Co NV Share Price Forecast
-
What is the NewAmsterdam Pharma Co NV stock price today?The NewAmsterdam Pharma Co NV stock price is 24.95 USD today.
-
Will NAMS stock go up or go down?NewAmsterdam Pharma Co NV> share price is forecast to RISE/FALL based on technical indicators
-
Is NewAmsterdam Pharma Co NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NewAmsterdam Pharma Co NV is overvalued.
Is NewAmsterdam Pharma Co NV Stock a Buy?
-
NewAmsterdam Pharma Co NV share price is 24.95 while NAMS 8-day exponential moving average is 25.58, which is a Sell signal.
-
The stock price of NAMS is 24.95 while NewAmsterdam Pharma Co NV 20-day EMA is 25.00, which makes it a Sell.
-
NewAmsterdam Pharma Co NV 50-day exponential moving average is 23.12 while NAMS share price is 24.95, making it a Buy technically.
-
NAMS stock price is 24.95 and NewAmsterdam Pharma Co NV 200-day simple moving average is 19.69, creating a Buy signal.
Fundamental Analysis of NewAmsterdam Pharma Co NV
Is NewAmsterdam Pharma Co NV a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.08 per share.
Technical Analysis of NewAmsterdam Pharma Co NV
Should I short NewAmsterdam Pharma Co NV stock?
-
NAMS Moving Average Covergence Divergence (MACD) indicator is 0.9, suggesting NewAmsterdam Pharma Co NV is a Buy
-
NewAmsterdam Pharma Co NV Relative Strength Index (RSI) is 53.26, which suggest NewAmsterdam Pharma Co NV is overbought
-
The Bollinger Bands (25) for NewAmsterdam Pharma Co NV is (21.75 - 27.23), which suggest NewAmsterdam Pharma Co NV is a Buy
-
The Bollinger Bands (100) for NewAmsterdam Pharma Co NV is (16.19 - 23.71), which suggest NewAmsterdam Pharma Co NV is a Buy
* NewAmsterdam Pharma Co NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.